Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Sata

Showing results (131-140 of 416) with videos related to

Pageof 42
Sort By:
Oncology Reports|June 6, 2007
X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissuesRyosuke Sakemi, Hirohisa Yano, Sachiko Ogasawara, et al.
Microbiology and Immunology|November 23, 2006
New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patientsYi Wang, Yukari Takao, Mamoru Harada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 14, 2013
Pathological characteristics of patients who develop hepatocellular carcinoma with negative results of both serous hepatitis B surface antigen and hepatitis C virus antibodyReiichiro Kondo, Osamu Nakashima, Michio Sata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Clinical efficacy of combination therapy with ME3738 and pegylated interferon-alpha-2a in patients with hepatitis C virus genotype 1Toshiji Saibara, Nobuyuki Enomoto, Shuichi Kaneko, et al.
International Journal of Molecular Medicine|July 3, 2010
HCC develops even in the early stage of chronic liver disease in elderly patients with HCV infectionAkio Takata, Ryoko Kuromatsu, Eiji Ando, et al.
Molecular Medicine Reports|April 12, 2011
Transarterial chemoembolization as salvage therapy after unsuccessful hepatic arterial infusion chemotherapy in advanced hepatocellular carcinomaKazuta Fukumori, Yoichi Yano, Eiji Ando, et al.
Clinical Pharmacology in Drug Development|August 8, 2017
Luseogliflozin, an SGLT2 Inhibitor, in Japanese Patients With Mild/Moderate Hepatic Impairment: A Pharmacokinetic StudyYoshishige Samukawa, Michio Sata, Kenichi Furihata, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|May 2, 2003
[A case of advanced hepatocelluar carcinoma achieving a complete response following the hepatic arterial infusion chemotherapy and subsequent lipiodolization]Kazuta Fukumori, Eiji Ando, Fumihiko Yamashita, et al.
The Kurume Medical Journal|September 16, 2003
A case report of primary hepatic squamous cell carcinoma that remarkably responded to low dose arterial injection of anti-cancer drugsRyohei Kaji, Nozomi Sasaki, Ikuo Tateishi, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|April 18, 2012
N-butyl-2-cyanoacrylate (histoacryl) glue in the right atrium after endoscopic injection for a ruptured duodenal varix: complication of histoacryl injectionKenji Miyakoda, Hidetoshi Takedatsu, Keigo Emori, et al.
Pageof 42

Showing results (131-140 of 416) with videos related to

Sort By:
Pageof 42
Oncology Reports|June 6, 2007
X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissuesRyosuke Sakemi, Hirohisa Yano, Sachiko Ogasawara, et al.
Microbiology and Immunology|November 23, 2006
New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patientsYi Wang, Yukari Takao, Mamoru Harada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 14, 2013
Pathological characteristics of patients who develop hepatocellular carcinoma with negative results of both serous hepatitis B surface antigen and hepatitis C virus antibodyReiichiro Kondo, Osamu Nakashima, Michio Sata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Clinical efficacy of combination therapy with ME3738 and pegylated interferon-alpha-2a in patients with hepatitis C virus genotype 1Toshiji Saibara, Nobuyuki Enomoto, Shuichi Kaneko, et al.
International Journal of Molecular Medicine|July 3, 2010
HCC develops even in the early stage of chronic liver disease in elderly patients with HCV infectionAkio Takata, Ryoko Kuromatsu, Eiji Ando, et al.
Molecular Medicine Reports|April 12, 2011
Transarterial chemoembolization as salvage therapy after unsuccessful hepatic arterial infusion chemotherapy in advanced hepatocellular carcinomaKazuta Fukumori, Yoichi Yano, Eiji Ando, et al.
Clinical Pharmacology in Drug Development|August 8, 2017
Luseogliflozin, an SGLT2 Inhibitor, in Japanese Patients With Mild/Moderate Hepatic Impairment: A Pharmacokinetic StudyYoshishige Samukawa, Michio Sata, Kenichi Furihata, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|May 2, 2003
[A case of advanced hepatocelluar carcinoma achieving a complete response following the hepatic arterial infusion chemotherapy and subsequent lipiodolization]Kazuta Fukumori, Eiji Ando, Fumihiko Yamashita, et al.
The Kurume Medical Journal|September 16, 2003
A case report of primary hepatic squamous cell carcinoma that remarkably responded to low dose arterial injection of anti-cancer drugsRyohei Kaji, Nozomi Sasaki, Ikuo Tateishi, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|April 18, 2012
N-butyl-2-cyanoacrylate (histoacryl) glue in the right atrium after endoscopic injection for a ruptured duodenal varix: complication of histoacryl injectionKenji Miyakoda, Hidetoshi Takedatsu, Keigo Emori, et al.
Pageof 42